Related Experiment Videos
p53 mutation and expression in lymphoma
D J Adamson1, W D Thompson, A A Dawson
1Department of Medical Genetics, University of Aberdeen Medical School, Foresterhill, UK.
British Journal of Cancer
|July 1, 1995
Summary
p53 gene mutations and abnormal expression were investigated in lymphomas. Abnormalities of p53 were more frequent in high-grade non-Hodgkin
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 tumor suppressor gene plays a critical role in preventing cancer.
- Alterations in p53 function are implicated in lymphomagenesis.
- Understanding p53 mutations and expression is crucial for lymphoma research.
Purpose of the Study:
- To investigate the frequency and correlation of p53 gene mutations and abnormal protein expression in lymphomas.
- To compare p53 abnormalities between Hodgkin's disease and non-Hodgkin's lymphoma (NHL).
- To assess the relationship between p53 status and lymphoma grade.
Main Methods:
- Analysis of 38 lymphoma cases (5 Hodgkin's disease, 33 NHL).
- Screening of p53 exons 5-8 for missense mutations using single-strand conformation polymorphism (SSCP) analysis.
- Detection of p53 overexpression using CM1 polyclonal antibody immunocytochemistry.
Main Results:
- Three missense mutations in p53 were identified in three NHL cases.
- Only two of the three mutation-positive tumors showed abnormal p53 expression by CM1.
- Seven of nine tumors with positive CM1 staining lacked detectable point mutations.
- p53 overexpression was more common in high-grade NHL (5/9) than low-grade NHL (3/24).
Conclusions:
- p53 abnormalities are more prevalent in high-grade non-Hodgkin's lymphoma compared to low-grade NHL.
- Positive immunocytochemistry for p53 overexpression does not reliably indicate the presence of p53 gene mutations.
- Further investigation is needed to elucidate the complex relationship between p53 mutations and expression in lymphomas.